Skip to Main Content

Other Haematological

Trial HEMA-Med
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Belfast City Hospital
Information

A Phase I/II Open-Label, Multi-centre Study to Assess the Safety and Tolerability of Roginolisib in Combination with Ruxolitinib in Patients with Myelofibrosis (MF) who are Unresponsive to JAK inhibitors

Trial Open Yes
Click Here to view trial summary
Trial MITHRIDATE
Cancer Type Haematological Cancers and Other Haematological
Hospital(s) Belfast City Hospital
Information

A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

Trial Open Yes